CD43^-/- septic mice exhibit decreased frequencies of apoptotic CD4⁺ and CD8⁺ naïve T cells as compared to WT septic mice. by Katherine T. Fay (2576998)

“…D) CD43^-/- mice exhibited a decreased frequency of apoptotic naïve CD4⁺ T cells, defined as 7-AAD⁺ Annexin V⁺ CD44^LO CD62L^HI CD8⁺ cells, compared to WT mice after sepsis induction (7.2±1.1 vs 14.8±2.2, p = 0.02). …”

Cephalometric measurement points. by Lijuan Liu (136685)

Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study by Jilles M. Fermont (3746068)

“…In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. …”

A <i>mer2</i> point mutant affected for its interaction with Spp1 mimics the meiotic phenotype of <i>spp1∆</i>. by Céline Adam (320770)

Comparison of the histopathological changes after KA/E2 treatment in WT and TLR2 KO mice. by Mi-Kyung Park (56053)

Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

“…</p><p>Conclusions</p><p>In a mostly HIV patient population, RPR titer can show more than four-fold spontaneous increase or decrease within 1–3 months. …”

Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

“…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”

Mice with a decrease in α7 expression show no behavioral preference to a conditioned odor. by Jennifer L. Hellier (326477)

The phenotype of <i>Ttbk2</i>^{<i>sca11/sca11</i>} embryos is identical to that of the null allele. by Emily Bowie (543704)

ENaC activity is decreased in oocytes expressing wild type S protein. by Germán Ricardo Magaña-Ávila (18446799)

Role of Ser77 in ACER3 catalytic site. by Jae Kyo Yi (13570063)

Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

Structure of ADPR2 and ACER3. by Jae Kyo Yi (13570063)

The kinetics of ACER3 and mutants. by Jae Kyo Yi (13570063)

Inhibitor assay of ACER3. by Jae Kyo Yi (13570063)

HPLC chromatogram of standard NBD-C₁₂-FA. by Jae Kyo Yi (13570063)

Comparison between TLC and HPLC used in this study. by Jae Kyo Yi (13570063)

Suggested ACER3 catalytic mechanism. by Jae Kyo Yi (13570063)

HPLC chromatogram of ACER3 reaction. by Jae Kyo Yi (13570063)

The effects of neutral and alkaline ceramidase inhibitors on ACER3 activity. by Jae Kyo Yi (13570063)